Balyasny Asset Management LLC Heska Corp Transaction History

Balyasny Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$84.23 - $147.57 $128,450 - $225,044	-1,525 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$122.89 - $171.74 $172,046 - $240,436	-1,400 Reduced 47.86%	1,525 $211,000
Q4 2021 Feb 14, 2022	BUY	$156.0 - $265.78 $456,300 - $777,406	2,925 New	2,925 $534,000
Q4 2019 Feb 14, 2020	SELL	$69.39 - $97.59 $232,178 - $326,536	-3,346 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$64.17 - $84.08 $214,712 - $281,331	3,346 New	3,346 $237,000
Q2 2018 Aug 14, 2018	SELL	$74.5 - $108.91 $212,399 - $310,502	-2,851 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$58.36 - $83.18 $166,384 - $237,146	2,851 New	2,851 $225,000

26K

Ticker HSKA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,818,900
Description
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.